Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Einstein (São Paulo)
Print version ISSN 1679-4508
Abstract
GOLMIA, Ricardo Prado and SCHEINBERG, Morton Aaron. Retention rates of infliximab and tocilizumab during a 3-year period in a Brazilian hospital. Einstein (São Paulo) [online]. 2013, vol.11, n.4, pp.492-494. ISSN 1679-4508. https://doi.org/10.1590/S1679-45082013000400015.
OBJECTIVE: To compare the efficacy and the period of use of tocilizumab and infliximab during treatment of rheumatoid arthritis patients. METHODS: The period of use of two biologics with different mechanisms of action were compared in treatment of rheumatoid arthritis patients. RES: ULTS: Both medications showed efficacy, but the period of use with no loss of efficacy was longer in patients receiving tocilizumab when compared to infliximab. CONCLUSION: Tocilizumab maintains a period of use significantly longer as compared with infliximab in patients with rheumatoid arthritis treated at a single organization.
Keywords : Biological agents; Arthritis, rheumatoid [drug therapy]; Antibodies, monoclonal [therapeutic use].